Buy PT-141: Prescription Prices and Research Vials Compared
Checked, not rated · Updated 3 October 2026
You need a prescription to buy PT-141 legally in the US. With one, Vyleesi costs $99 for a 4-dose box without insurance, says its maker, Cosette Pharmaceuticals (as of 3 October 2026).
Research vendors also sell research-labelled PT-141, which is not the approved medicine.
- Class
- Melanocortin receptor agonist
- Background
- Approved for premenopausal women with acquired, generalised hypoactive sexual desire disorder.
- Human evidence
- Strong human evidence
The evidence, risks and legal detail: my PT-141 guide. Label dosing: PT-141 dosage.
How to buy PT-141 legally
US status: FDA-approved as Vyleesi (bremelanotide), a 1.75 mg autoinjector for premenopausal women with acquired, generalized hypoactive sexual desire disorder; not indicated for men, and no nasal form is approved.
Prescription needed? Yes. Vyleesi is a prescription product, and compounded PT-141 is also dispensed only on a prescription after a consultation.
Vyleesi through your clinician and BlinkRx
Legal routeThe prescription goes to BlinkRx, the manufacturer's pharmacy partner, which checks coverage, applies savings and delivers to your home. Patients on Medicaid, TRICARE or other government plans can't use the manufacturer's assistance.
| Product | Seller | Price | Size and terms |
|---|---|---|---|
| Vyleesi, no insurance coverage | Vyleesi.com (Cosette Pharmaceuticals) | $99.00as of 3 October 2026 | 4-dose box (4 x 1.75 mg autoinjectors); per 4-dose box. |
| Vyleesi, most commercially insured patients | Vyleesi.com (Cosette Pharmaceuticals) | $0.00as of 3 October 2026 | 4-dose box (4 x 1.75 mg autoinjectors); per 4-dose box. |
Vyleesi through the manufacturer-linked telemedicine partner
Legal routeBeyondMD (Prescribery) runs an online questionnaire and a physician review, then a pharmacy partner fills and ships. Its 'never more than $149' cash figure conflicts with the $99 on vyleesi.com.
| Product | Seller | Price | Size and terms |
|---|---|---|---|
| Vyleesi, cash ceiling | BeyondMD / Prescribery (Vyleesi telemedicine partner) | $149.00as of 3 October 2026 | one box; per box per month (maximum). |
| Doctor consultation for Vyleesi | BeyondMD / Prescribery | $15.00as of 3 October 2026 | one consultation; one-time, non-refundable.Shown struck through from $49. |
Compounded bremelanotide through telehealth
Legal routeSold on prescription as compounded, not FDA-approved products, often as nasal sprays and to men, outside the Vyleesi label. FDA's 503A rules let compounders use a component of an FDA-approved drug, and bremelanotide acetate is Vyleesi's active ingredient; I found no bremelanotide-specific FDA compounding statement since the 2019 approval.
| Product | Seller | Price | Size and terms |
|---|---|---|---|
| Compounded bremelanotide nasal solution, subscription | Wisp (hellowisp.com) | $175.00as of 3 October 2026 | 1-month supply; per month. |
| Compounded bremelanotide nasal solution, one-time | Wisp (hellowisp.com) | $200.00as of 3 October 2026 | 1-month supply; one-time. |
| Compounded PT-141 for men | Hone Health | $130.00as of 3 October 2026 | monthly; per month plus membership.Membership is Basic $25 or Premium $155 a month; a $65 biomarker test is also required. |
| Compounded PT-141 nasal spray, 5 mg/mL | MintRx | $180.00as of 3 October 2026 | one prescribed order; per prescribed order.Price shown in the PT-141 listing on MintRx's oxytocin page. |
| Compounded PT-141 injection, 20 mg vial with supplies | MintRx | $180.00as of 3 October 2026 | one prescribed order; per prescribed order.Price shown in the injection listing on MintRx's PT-141 nasal spray page. |
Prices come from each seller's, pharmacy's or manufacturer's own page on the date shown, and they change often. "Legal status unclear" means the sources conflict or FDA has not ruled. How prescribing online works: telehealth peptide prescribing.
Research-labelled PT-141 (not the approved medicine)
Vyleesi is a sterile 1.75 mg/0.3 mL autoinjector made under an NDA, with a label that limits use to one dose in 24 hours and no more than 8 a month, and lists uncontrolled hypertension and known cardiovascular disease as contraindications. A research vial or spray has no verified content, dose or sterility, and no nasal form has ever been approved. FDA's 24 August 2026 warning letters named research-sold 'PT-141' at four sellers (Peptide Partners, Peak Performance Peptides, Royal Peptides and NuScience Peptides) as unapproved new drugs, and said research-use-only labels do not change that.
Compared with the approved medicine, a research vial has not been reviewed by FDA, is labelled not for human use, and is tested only as the seller chooses.
FDA warning letters cited on this page: Warning letter: Peptide Partners LLC (24 Aug 2026); Warning letter: NuScience Peptides LLC (24 Aug 2026); Warning letter: Peak Performance Peptides (24 Aug 2026); Warning letter: Royal Peptides LLC (24 Aug 2026); Warning letter: Tailor Made Compounding (1 Apr 2020).
The checklist results come from my review of each vendor and cover the whole store. A vendor can publish COAs for some products and not others. The order is not a ranking.
| Vendor | Product | Price | FDA record | Names its lab | Batch COAs | Card payment | Link |
|---|---|---|---|---|---|---|---|
| Next Level PharmMy Next Level Pharm review | 10 mg vial | $30.99as of 3 October 2026 | No warning letter found | Yes | Yes | Yes | View product → |
| Spartan PeptidesMy Spartan Peptides review | 10 mg vial | $139.00as of 3 October 2026 | No warning letter found | Yes | Not verified | Not verified | View product → |
| BioEdge Research LabsMy BioEdge Research Labs review | 10 mg vial | $45.00as of 3 October 2026 | No warning letter found | Yes | Yes | Not verified | View product → |
Prices are for the product named, as shown on the vendor's own product page on the date given. They change often. Checklist results were verified on 3 October 2026. All vendors and how they compare.
What a research PT-141 COA should show
A certificate of analysis (COA) is the lab report for one batch. For PT-141, check these:
- Identity by mass spectrometry, with the expected and the measured mass side by side. For PT-141, expect about 1,025.2 Da (C50H68N14O10).
- Purity by HPLC for this batch, shown as a chromatogram as well as a percentage.
- A lot number that matches your vial or pack, the test date and the lab's name, so you can confirm the certificate on the lab's own site.
A purity figure does not cover sterility or bacterial endotoxins; a COA covers those only if it reports separate tests for them. Line by line: how to read a peptide COA.
Red flags when buying research PT-141
- A research vial presented as the approved medicine, or sold to you as a treatment.
- No certificate of analysis for the batch you will receive, or one without a lot number or a named lab.
- Dosing instructions or treatment claims for people on the product page.
- An FDA warning letter naming the seller. Search fda.gov before you pay.
- No way to pay with buyer protection, such as a credit card.
Common questions
How much is Vyleesi without insurance?
Vyleesi.com says a 4-dose box costs $99 without insurance coverage, and most commercially insured patients pay $0 (3 October 2026). The manufacturer-linked telemedicine partner says cash is never more than $149 a month per box, plus a consultation fee. Patients on Medicaid or TRICARE are not eligible for the manufacturer's help.
Is PT-141 approved for men?
No. The Vyleesi label says it is not indicated in men, in postmenopausal women, or to enhance sexual performance. Compounded PT-141 sold to men is outside the label.
Who should not take PT-141?
The Vyleesi label lists uncontrolled high blood pressure and known cardiovascular disease as contraindications. Blood pressure rises and heart rate falls briefly after each dose, so it is not recommended for people at high cardiovascular risk.
What are the common side effects of PT-141?
In the pooled Phase 3 trials behind the Vyleesi label: nausea in 40% (against 1% on placebo), flushing 20.3%, injection-site reactions 13.2%, headache 11.3% and vomiting 4.8%.
How long does it take for PT-141 nasal spray to work?
No nasal form is approved. The Vyleesi label says to inject at least 45 minutes before sexual activity. In a study of the developer's nasal spray in men, the first erection came about 30 minutes after a dose, but that spray was never approved.
Where can I buy PT-141?
Legally, only with a prescription. The legal routes I checked: Vyleesi through your clinician and BlinkRx; Vyleesi through the manufacturer-linked telemedicine partner; Compounded bremelanotide through telehealth. Vyleesi costs $99 for a 4-dose box without insurance, says its maker, Cosette Pharmaceuticals (as of 3 October 2026). Research vendors also sell research-labelled PT-141 (Next Level Pharm, Spartan Peptides and BioEdge Research Labs), labelled not for human use; it is not the approved medicine.
Is PT-141 for sale legally?
Only with a prescription. Vyleesi is a prescription product, and compounded PT-141 is also dispensed only on a prescription after a consultation. This is general information, not legal advice.
Sources
- Vendor checks: my review of each vendor, on the date shown under the table. Products and prices: each vendor's own product page.
- Route prices: each seller's, pharmacy's or manufacturer's own page, on the date shown in the table.
- Legal status, class and evidence: my PT-141 guide, which cites its sources. Formula, mass and sequence: the structure record shown on that guide, checked against two sources.
- Drugs@FDA: VYLEESI NDA 210557, US Food and Drug Administration.
- VYLEESI prescribing information, DailyMed, National Library of Medicine (label by Cosette Pharmaceuticals).
- Vyleesi: cost, savings and how to get it, Cosette Pharmaceuticals.
- Vyleesi telemedicine visit and cash price, BeyondMD / Prescribery.
- Bremelanotide (PT-141) nasal solution, Wisp.
- PT-141 for men, Hone Health.
- PT-141 nasal spray and injection, MintRx.
- Bulk drug substances under section 503A, US Food and Drug Administration.
- Warning letter: Peptide Partners LLC (24 Aug 2026), US Food and Drug Administration.
- Warning letter: NuScience Peptides LLC (24 Aug 2026), US Food and Drug Administration.
- Warning letter: Peak Performance Peptides (24 Aug 2026), US Food and Drug Administration.
- Warning letter: Royal Peptides LLC (24 Aug 2026), US Food and Drug Administration.
- Warning letter: Tailor Made Compounding (1 Apr 2020), US Food and Drug Administration.
- MintRx oxytocin nasal spray page (also lists the PT-141 nasal spray price), MintRx.